David A. Hadley, MD, urologist at Kettering Health in Kettering, Ohio, focuses on diagnosing and treating benign prostatic hyperplasia (BPH), emphasizing office evaluation, diagnostic limitations, and non-surgical management strategies. In this 9-minute presentation, Hadley discusses the inadequacies of current diagnostic tools, noting that the complexity of diagnosing BPH underscores the need for a hybrid approach. He advocates for a validated bladder diary for more accurate patient assessment.
The presentation then examines the AUA guidelines for medical therapy, noting the increasing role of daily tadalafil or tamsulosin as a first-line treatment for BPH. Dr. Hadley also highlights the correlation between PSA levels and prostate size as critical factors in determining appropriate treatment strategies. A panel of other urology experts chimes in on the discussion, led by Dr. Hadley as well.
The presentation then examines the AUA guidelines for medical therapy, noting the increasing role of daily tadalafil or tamsulosin as a first-line treatment for BPH. Dr. Hadley also highlights the correlation between PSA levels and prostate size as critical factors in determining appropriate treatment strategies. A panel of other urology experts chimes in on the discussion, led by Dr. Hadley as well.
- Category
- Urology

Be the first to comment